Tevogen Bio Holdings (TVGN)
NASDAQ:TVGN

Tevogen Bio Holdings (TVGN) Financial Statements

30 Followers

Tevogen Bio Holdings Financial Overview

Tevogen Bio Holdings's market cap is currently ―. The company's EPS TTM is $-0.345; its P/E ratio is -2.07; Tevogen Bio Holdings is scheduled to report earnings on May 29, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT$ 11.42M$ -278.75K$ 1.24M$ -212.79K$ -198.83K
EBITDA$ 11.52M$ -278.75K$ 1.24M$ -212.79K$ -198.83K
Net Income Common Stockholders$ 10.51M$ -278.75K$ 1.24M$ 2.61M$ 1.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.32M$ 347.55K$ 52.28K$ 129.19K$ 143.05K
Total Assets$ 3.36M$ 26.41M$ 25.47M$ 357.14M$ 354.54M
Total Debt$ 2.08M$ 625.69K$ 0.00$ 0.00$ 0.00
Net Debt$ 760.47K$ 278.15K$ -52.28K$ -129.19K$ -143.05K
Total Liabilities$ 9.17M$ 16.56M$ 15.43M$ 15.06M$ 15.08M
Stockholders Equity$ -5.80M$ -16.16M$ -15.33M$ 342.08M$ 339.47M
Cash Flow-
Free Cash Flow$ -2.16M$ -208.46K$ -76.90K$ -13.86K$ -42.60K
Operating Cash Flow$ -2.16M$ -208.46K$ -76.90K$ -13.86K$ -42.60K
Investing Cash Flow--$ 333.27M--
Financing Cash Flow$ 2.43M-$ -333.27M--
Currency in USD

Tevogen Bio Holdings Earnings and Revenue History

Tevogen Bio Holdings Debt to Assets

Tevogen Bio Holdings Cash Flow

Tevogen Bio Holdings Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis